• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简易性:基于网络的高通量癌细胞系筛选的可视化与分析

Simplicity: Web-Based Visualization and Analysis of High-Throughput Cancer Cell Line Screens.

作者信息

Ling Alexander L, Zhang Weijie, Lee Adam, Xia Yunong, Su Mei-Chi, Gruener Robert F, Jena Sampreeti, Huang Yingbo, Pareek Siddhika, Shan Yuting, Stephanie Huang R

机构信息

Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Hale Building for Transformative Medicine, 4th and 8th floor, Brigham and Women's Hospital; 60 Fenwood Road, Boston, MA 02116.

Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

J Cancer Sci Clin Ther. 2023;7(4):249-252. doi: 10.26502/jcsct.5079217. Epub 2023 Dec 8.

DOI:10.26502/jcsct.5079217
PMID:38435702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906814/
Abstract

High-throughput drug screens are a powerful tool for cancer drug development. However, the results of such screens are often made available only as raw data, which is intractable for researchers without informatics skills, or as highly processed summary statistics, which can lack essential information for translating screening results into clinically meaningful discoveries. To improve the usability of these datasets, we developed Simplicity, a robust and user-friendly web interface for visualizing, exploring, and summarizing raw and processed data from high- throughput drug screens. Importantly, Simplicity allows for easy recalculation of summary statistics at user-defined drug concentrations. This allows Simplicity's outputs to be used with methods that rely on statistics being calculated at clinically relevant doses. Simplicity can be freely accessed at https://oncotherapyinformatics.org/simplicity/.

摘要

高通量药物筛选是癌症药物开发的有力工具。然而,此类筛选的结果通常仅以原始数据的形式提供,这对于没有信息学技能的研究人员来说难以处理,或者以经过高度处理的汇总统计数据的形式提供,而这些汇总统计数据可能缺乏将筛选结果转化为具有临床意义的发现所需的关键信息。为了提高这些数据集的可用性,我们开发了Simplicity,这是一个强大且用户友好的网络界面,用于可视化、探索和汇总来自高通量药物筛选的原始数据和处理后的数据。重要的是,Simplicity允许在用户定义的药物浓度下轻松重新计算汇总统计数据。这使得Simplicity的输出结果能够与依赖于在临床相关剂量下计算统计数据的方法一起使用。可通过https://oncotherapyinformatics.org/simplicity/免费访问Simplicity。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f94/10906814/8243a121007e/nihms-1962041-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f94/10906814/8243a121007e/nihms-1962041-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f94/10906814/8243a121007e/nihms-1962041-f0001.jpg

相似文献

1
Simplicity: Web-Based Visualization and Analysis of High-Throughput Cancer Cell Line Screens.简易性:基于网络的高通量癌细胞系筛选的可视化与分析
J Cancer Sci Clin Ther. 2023;7(4):249-252. doi: 10.26502/jcsct.5079217. Epub 2023 Dec 8.
2
Simplicity: web-based visualization and analysis of high-throughput cancer cell line screens.简易性:基于网络的高通量癌细胞系筛选可视化与分析
bioRxiv. 2023 Sep 12:2023.09.08.556619. doi: 10.1101/2023.09.08.556619.
3
TOPS: a versatile software tool for statistical analysis and visualization of combinatorial gene-gene and gene-drug interaction screens.TOPS:一个用于组合基因-基因和基因-药物相互作用筛选的统计分析和可视化的通用软件工具。
BMC Bioinformatics. 2014 Apr 8;15:98. doi: 10.1186/1471-2105-15-98.
4
HTSvis: a web app for exploratory data analysis and visualization of arrayed high-throughput screens.HTSvis:一个用于排列高通量筛选的探索性数据分析和可视化的网络应用程序。
Bioinformatics. 2017 Sep 15;33(18):2960-2962. doi: 10.1093/bioinformatics/btx319.
5
Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models.通过 compaRe 的全面、无偏的多参数高通量筛选,在 AML 模型中发现了有效且微妙的药物反应。
Elife. 2022 Feb 15;11:e73760. doi: 10.7554/eLife.73760.
6
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets.大规模稀疏药物组合数据集的协同作用的统计评估和可视化。
BMC Bioinformatics. 2019 Feb 18;20(1):83. doi: 10.1186/s12859-019-2642-7.
7
Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens.在高通量RNA干扰筛选的背景下,使用带有改进间隙统计量的迭代聚类合并来进行在线表型发现。
BMC Bioinformatics. 2008 Jun 5;9:264. doi: 10.1186/1471-2105-9-264.
8
VCF-Server: A web-based visualization tool for high-throughput variant data mining and management.VCF-Server:一个基于网络的高通量变异数据挖掘和管理的可视化工具。
Mol Genet Genomic Med. 2019 Jul;7(7):e00641. doi: 10.1002/mgg3.641. Epub 2019 May 24.
9
GUItars: a GUI tool for analysis of high-throughput RNA interference screening data.GUItars:一个用于高通量 RNA 干扰筛选数据分析的 GUI 工具。
PLoS One. 2012;7(11):e49386. doi: 10.1371/journal.pone.0049386. Epub 2012 Nov 20.
10
CrossCheck: an open-source web tool for high-throughput screen data analysis.CrossCheck:一个用于高通量筛选数据分析的开源网络工具。
Sci Rep. 2017 Jul 19;7(1):5855. doi: 10.1038/s41598-017-05960-3.

引用本文的文献

1
Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis.通过计算建模识别靶向以糖酵解增强为特征的转移性去势抵抗性前列腺癌的药物
Pharmaceuticals (Basel). 2024 Apr 29;17(5):569. doi: 10.3390/ph17050569.
2
Integration of Pan-Cancer Cell Line and Single-Cell Transcriptomic Profiles Enables Inference of Therapeutic Vulnerabilities in Heterogeneous Tumors.泛癌系和单细胞转录组谱的整合能够推断异质性肿瘤的治疗弱点。
Cancer Res. 2024 Jun 14;84(12):2021-2033. doi: 10.1158/0008-5472.CAN-23-3005.
3
A Web Application for Predicting Drug Combination Efficacy Using Monotherapy Data and IDACombo.

本文引用的文献

1
A Web Application for Predicting Drug Combination Efficacy Using Monotherapy Data and IDACombo.一种使用单药治疗数据和IDACombo预测药物联合疗效的网络应用程序。
J Cancer Sci Clin Ther. 2024;7(4):253-258. doi: 10.26502/jcsct.5079218. Epub 2023 Dec 8.
2
Computationally predicting clinical drug combination efficacy with cancer cell line screens and independent drug action.基于癌细胞系筛选和独立药物作用的计算预测临床药物组合疗效。
Nat Commun. 2020 Nov 17;11(1):5848. doi: 10.1038/s41467-020-19563-6.
3
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.
一种使用单药治疗数据和IDACombo预测药物联合疗效的网络应用程序。
J Cancer Sci Clin Ther. 2024;7(4):253-258. doi: 10.26502/jcsct.5079218. Epub 2023 Dec 8.
通过系统生存力分析发现非肿瘤药物的抗癌潜力。
Nat Cancer. 2020 Feb;1(2):235-248. doi: 10.1038/s43018-019-0018-6. Epub 2020 Jan 20.
4
PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.PharmacoDB:一个用于挖掘体外抗癌药物筛选研究的综合数据库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D994-D1002. doi: 10.1093/nar/gkx911.
5
More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens.不只是为了寻找治疗方法:高通量癌细胞系筛选的前景与挑战。
Pharmacol Ther. 2018 Nov;191:178-189. doi: 10.1016/j.pharmthera.2018.06.014. Epub 2018 Jun 25.
6
Defining a Cancer Dependency Map.定义癌症依赖图谱。
Cell. 2017 Jul 27;170(3):564-576.e16. doi: 10.1016/j.cell.2017.06.010.
7
A Landscape of Pharmacogenomic Interactions in Cancer.癌症中的药物基因组学相互作用全景
Cell. 2016 Jul 28;166(3):740-754. doi: 10.1016/j.cell.2016.06.017. Epub 2016 Jul 7.
8
Correlating chemical sensitivity and basal gene expression reveals mechanism of action.关联化学敏感性与基础基因表达揭示作用机制。
Nat Chem Biol. 2016 Feb;12(2):109-16. doi: 10.1038/nchembio.1986. Epub 2015 Dec 14.
9
PharmacoGx: an R package for analysis of large pharmacogenomic datasets.PharmacoGx:用于分析大型药物基因组数据集的 R 包。
Bioinformatics. 2016 Apr 15;32(8):1244-6. doi: 10.1093/bioinformatics/btv723. Epub 2015 Dec 9.
10
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.在大规模小分子敏感性数据集中利用连通性
Cancer Discov. 2015 Nov;5(11):1210-23. doi: 10.1158/2159-8290.CD-15-0235. Epub 2015 Oct 19.